Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Guardant Health Inc (NASDAQ: GH) closed at $105.22 in the last session, down -2.95% from day before closing price of $108.42. In other words, the price has decreased by -$2.95 from its previous closing price. On the day, 1.67 million shares were traded. GH stock price reached its highest trading level at $108.125 during the session, while it also had its lowest trading level at $104.57.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 01 ’25 when Monroe Terilyn J. bought 55,167 shares for $105.97 per share.
Tariq Musa sold 116 shares of GH for $11,165 on Nov 19 ’25. The Director now owns 7,859 shares after completing the transaction at $96.25 per share. On Nov 19 ’25, another insider, Tariq Musa, who serves as the Director of the company, bought 116 shares for $96.25 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 13665387520 and an Enterprise Value of 14008406016. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.08. Its current Enterprise Value per Revenue stands at 15.521 whereas that against EBITDA is -34.83.
Stock Price History:
The Beta on a monthly basis for GH is 1.58, which has changed by 2.0301845 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $112.43, while it has fallen to a 52-week low of $29.91. The 50-Day Moving Average of the stock is 31.42%, while the 200-Day Moving Average is calculated to be 88.21%.
Shares Statistics:
According to the various share statistics, GH traded on average about 2.75M shares per day over the past 3-months and 2636520 shares per day over the past 10 days. A total of 125.01M shares are outstanding, with a floating share count of 124.15M. Insiders hold about 4.04% of the company’s shares, while institutions hold 96.59% stake in the company. Shares short for GH as of 1763078400 were 8955320 with a Short Ratio of 3.26, compared to 1760486400 on 8273789. Therefore, it implies a Short% of Shares Outstanding of 8955320 and a Short% of Float of 7.22.
Earnings Estimates
As of right now, 15.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.29 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$1.73 and -$1.91 for the fiscal current year, implying an average EPS of -$1.79. EPS for the following year is -$1.44, with 17.0 analysts recommending between -$0.89 and -$2.31.
Revenue Estimates
According to 19 analysts,. The current quarter’s revenue is expected to be $267.6M. It ranges from a high estimate of $270M to a low estimate of $264.6M. As of. The current estimate, Guardant Health Inc’s year-ago sales were $201.81MFor the next quarter, 19 analysts are estimating revenue of $271M. There is a high estimate of $284.1M for the next quarter, whereas the lowest estimate is $255.92M.
A total of 23 analysts have provided revenue estimates for GH’s current fiscal year. The highest revenue estimate was $970.1M, while the lowest revenue estimate was $965.3M, resulting in an average revenue estimate of $968.42M. In the same quarter a year ago, actual revenue was $739.02MBased on 22 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.32B and the low estimate is $1.16B.
